1 Stock I'd Avoid at All Costs
Ever since the coronavirus pandemic hit, the cannabis industry has been on fire. Marijuana sales got a boost amid lockdowns both in Canada and the U.S., and continued expansion of state legalization acted as an added benefit to rising U.S. sales.
Canada, however, has faced many external headwinds, including regulatory hurdles, a lack of legal stores, black-market sales cutting into traffic, and more. Despite a surge in pot sales across the country, Canadian producer Aurora Cannabis (NASDAQ: ACB) has failed to take advantage. The company sells medical and recreational products in the Great White North, and I fear its less-than-desirable performance so far this year is unlikely to improve anytime soon.
Image source: Getty Images.
Source Fool.com
